Dr. Gregory M. Bolduc, MD

Dr. Bolduc practices at Weymouth Endoscopy in South Weymouth, Massachusetts.

Dr. Bolduc's NPI, 1821078767, was assigned on January 18, 2006. Dr. Bolduc graduated from SUNY Upstate Medical University in 1991. Dr. Bolduc holds Massachusetts license 78133.

Dr. Bolduc's primary practice is Weymouth Endoscopy, at 1085 Main Street, South Weymouth, MA 02190. The practice phone is (781) 331-2922.

Dr. Bolduc's primary practice is Weymouth Endoscopy in South Weymouth, Massachusetts. Dr. Bolduc is also affiliated with South Shore Hospital. The medical group on file is South Shore Medical Center. Dmand AI also links Dr. Bolduc to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bolduc practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Bolduc's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Bolduc is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Bolduc's licenses on file in 2 states: Massachusetts and Virginia.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroenteritis, gastrointestinal bleeding, irritable bowel syndrome (IBS) and pancreas or bile duct endoscopy (ERCP) among the conditions Dr. Bolduc treats.

CMS data shows 939 Medicare services from Dr. Bolduc across 12 procedure codes in 2024, for 608 Medicare patients. Medicare paid $102,703 for them.

CMS counts 608 Medicare patients who saw Dr. Bolduc in 2024. The largest group is 65 to 74, with 287 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bolduc's median patient age at 61, with 53% women.

In 2024, Dr. Bolduc wrote 1,504 Medicare Part D claims for 301 patients. 86% of them were for generic drugs. CMS names the drug for 1,325 of them, across 26 drugs with 11 or more claims each, at $204,409 in total drug cost. In 2023, CMS named 1,247 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 20 out of 100 for Dr. Bolduc for performance year 2024, reported individually. Dr. Bolduc accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bolduc as offering telehealth. CMS counts 169 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Bolduc, more than 87% of the clinicians it reports for that procedure.

CMS Open Payments shows 16 general payments to Dr. Bolduc from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Janssen Pharmaceuticals, Inc paid the most, $288.

Dmand AI lists 1 award for Dr. Bolduc.

Dr. Bolduc graduated from SUNY Upstate Medical University in 1991.

Dr. Bolduc is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.